1Tsung SH. Several conditions causing elevation of serum CK-MB andCK-BB .Am J Clin Pathol, 1981, 75:711-715.
2Adams JE, Abendschein DR, Jaffe AS. Biochemical markers of myocardial injury: is MB creatine kinase the choice for the 1990s. Circulation, 1993, 88:750-763.
3Bodor GS, Porter S, Landt Y, Ladenson JH. Development of monoclonal antibodies for an assay of cardiac troponin-I and preliminary results in suspected cases of myocardial infarction. Clin Chem, 1992,38:2203-2214.
4Adams JE Ⅲ, Schechtman KB, Landt Y, et al. Comparable detection of acute myocardial infarction by MB creatine kinase and cardiac tropnin I. Clin Chem, 1994, 40: 1291-1295.
5Adams JE Ⅲ, Sicard GA, Allen BT, et al. Diagnosis of perioperative myocardial infarction with measurement of cardiac tropnin Ⅰ. N EnglJ Med, 1994,330:670-674.
6Etiams JP, Chocron G, Toubin G, et al. Use of cardiac troponin I as a marker of perioperative myocardial infarction. Ann Thorac Surg, 1995, 59:1192-1194.
7Adams JE Ⅲ, Davila Roman VG, Bessy PO, et al. Improved detection of cardiac condition with cardiac troponin Ⅰ. Am Heart J,1996, 131:308-312.
8Adams JE Ⅲ, Bodor GS, Davila Roman VG, et al. Cardiac troponin Ⅰ: a marker with high specificity for cardiac injury.Circulation, 1993, 88:101-106.
9Towbin JA, Gojarski RJ. Cardiac troponin I: a new Diagnostic gold standard of cardiac injury in children. J Pediatr, 1997, 130: 853-858.
10Mandema JW,Tuk B,Steveninck AL,et al.Pharmacokinetic-pharmacodynamic modeling of the central nervous system effects of midazolam and its main metabolite α-hydroxymidazolam in healthy volunteers[].Clinical Pharmacology and Therapeutics.1992
